Status not kept up to date
Improvement of RARP Outcomes Via 3D Printed/Virtual Prostate Models
NCT05982418 · Guy's and St Thomas' NHS Foundation Trust · Updated 8 Aug 2023
- What is being tested
- 3D Printed Models (3D printing facilities at GSTT); 3D Virtual Models (Innersight Labs)
- For
- Prostate Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 162 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 31 July 2023, ends 31 Jan 2024. Registered 8 Aug 2023.
- Results
- None posted yet.
In the researchers' words
Study the effect 3D printed or 3D virtual prostate models of a patient, when manipulated by surgeons during RARP, has on positive surgical margins and functional outcomes of patients. Our main hypothesis is that there is a reduction of positive resection margins and functional outcomes of patients undergoing RARP when surgeons are presented with 3D printed or 3D virtual patient-specific prostate models during surgery. Specifically, we hypothesize that the anatomical knowledge of surgeons that results from the manipulation of 3D printed/virtual models constructed from automated segmentations reduces positive resection margins and functional outcomes.
